Top Factor Driving Immunohistochemistry (IHC) Market Growth in 2025: Increase In Chronic Diseases Prevalence Boosts Immunohistochemistry (IHC) Market Growth

What market dynamics are playing a key role in accelerating the growth of the immunohistochemistry (ihc) market?
The immunohistochemistry (IHC) market is projected to grow due to the escalating occurrence of chronic illnesses. Chronic ailments are medical conditions that typically last for at least three months and can typically be managed but not completely cured. Immunohistochemistry proves beneficial in diagnosing such diseases including cancer, cardiovascular conditions, and others due to its distinct features like sensitivity, specificity (to determine unique antigens), swift results, and more. For instance, data from the Centers for Disease Control and Prevention, a national public health agency in the US, reveals that approximately 37.3 million people, accounting for 11.3% of the US population, had diabetes in 2022. Thus, the rising prevalence of chronic diseases is fueling the expansion of the immunohistochemistry (IHC) market.

Get Your Immunohistochemistry (IHC) Market Report Here:
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

How will the growth rate of the immunohistochemistry (ihc) market shape industry trends by 2034?
In recent times, the immunohistochemistry (IHC) market has seen robust growth. The market is projected to increase from $2.58 billion in 2024 to $2.78 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. Various factors such as the acceptance in clinical practice, industry standardization, the growth of cancer research, automation in labs, and advances in clinical diagnostics have contributed to the past growth.

The market for immunohistochemistry (IHC) is projected to experience a significant increase in the coming years, expanding to $4.13 billion by 2029, with a compound annual growth rate (CAGR) of 10.4%. This surge in the predicted period can be credited to the introduction of new participants in the market, needs in drug creation, the incorporation of biomedical research, diagnostic usages, as well as advancements in automation and digitization. The upcoming period is expected to witness trends such as multiplex IHC procedures, the merging of digital pathology, improved antibody specificity, automation and its standardization, and its utilization in biomarker discovery.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

What trends are poised to drive the future success of the immunohistochemistry (ihc) market?
In the immunohistochemistry (IHC) market, leading firms are emphasizing innovation and the use of high-quality reagents to improve diagnostic precision and tissue analysis effectiveness in diverse clinical and research settings. The advanced Neoflex multiomics mass spectrometry imaging (MSI) system is a bespoke imaging platform, developed for accurate tissue analysis, aiding researchers in moving from discovery to practical clinical applications with precise mass spectrometry techniques, especially important for spatially mapping biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US company specializing in the development and manufacturing of scientific instruments and analytical and diagnostic solutions, introduced its Neoflex Imaging Profiler, a matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) device for tissue imaging through mass spectrometry. The system not only bridges the gap from discovery imaging to clinical tissue research but also includes key features like Bruker's 10-kHz smartbeam 3D laser, superior imaging detectors, and compatibility with OME-TIFF files through SCiLS Scope software.

Which primary segments of the immunohistochemistry (ihc) market are driving growth and industry transformations?
The immunohistochemistry (IHC) market covered in this report is segmented -

1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:
1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes
3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media
4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9267

Which geographical regions are pioneering growth in the immunohistochemistry (ihc) market?
North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the immunohistochemistry (ihc) market landscape?
Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

What Is Covered In The Immunohistochemistry (IHC) Global Market Report?

• Market Size Forecast: Examine the immunohistochemistry (ihc) market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the immunohistochemistry (ihc) market for a structured understanding.
• Key Players Overview: Analyze major players in the immunohistochemistry (ihc) market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the immunohistochemistry (ihc) market.
• Segment Contributions: Evaluate how different segments drive overall growth in the immunohistochemistry (ihc) market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the immunohistochemistry (ihc) market.
• Industry Challenges: Identify potential risks and obstacles affecting the immunohistochemistry (ihc) market.
• Competitive Landscape: Review strategic developments in the immunohistochemistry (ihc) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.